US Congress Senate Bill 1348 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 10-0)
Status: Introduced on June 13 2017 - 25% progression, died in committee
Action: 2017-06-13 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill. A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017

Sen. Ron Wyden [D-OR]	Sen. Benjamin Cardin [D-MD]	Sen. Debbie Stabenow [D-MI]	Sen. Kirsten Gillibrand [D-NY]
Sen. Thomas Carper [D-DE]	Sen. Christopher Coons [D-DE]	Sen. Jon Tester [D-MT]	Sen. Tammy Duckworth [D-IL]
Sen. Robert Menendez [D-NJ]	Sen. Heidi Heitkamp [D-ND]

Date	Chamber	Action
2017-06-13	Senate	Read twice and referred to the Committee on Finance.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/senate-bill/1348/all-info
Text	https://www.congress.gov/115/bills/s1348/BILLS-115s1348is.pdf